MedPath

Appropriate Strategy of Surgical Treatment in Ischemic Diabetic Foot

Not Applicable
Conditions
Ischemic Diabetic Foot Ulcer
Popliteal Artery Stenosis
Diabetic Foot
Interventions
Procedure: Wound treatment
Procedure: Tibial transverse transport surgery
Procedure: Vascular intervention surgery
Registration Number
NCT04709887
Lead Sponsor
Peking University People's Hospital
Brief Summary

This cohort study aims to evaluate the outcomes of appropriate surgical treatment strategies in diabetic foot ulcers with different rate of popliteal artery stenosis(\<50% or ≥50%). In this study, patients with Texas university grade 2-4(stage C-D) ischemic diabetic foot ulcers will be included. Data of patients who underwent surgical treatment in the past will be retrospectively collected. The patients with follow-up time less than 12 months will continue to follow up. Also the postoperative patients will be prospectively collected. Effects of different surgical strategies, including wound healing therapy, interventional therapy and tibial transverse bone transport therapy will be measured by several indexes.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
332
Inclusion Criteria
  • Patients with diabetic foot, according to "Chinese Guidelines for Diagnosis and Treatment of Diabetic Foot (2017)".
  • Texas university grade 2-4(stage C-D) ischemic diabetic foot ulcers.
  • Have clear consciousness, not suffer from mental illness, can cooperate in research and treatment.
  • Patients who are informed, participate in the research voluntarily, and have signed the informed consent.
  • Have complete clinical data.
Exclusion Criteria
  • Patients with severe systemic infection, who need to be amputated immediately to save lives.
  • Patients with mental illness, who cannot cooperate to complete the adjustment and nursing of the external fixator.
  • Patients with severe cardiovascular and cerebrovascular diseases (such as severe cardiac insufficiency, severe sequelae of cerebrovascular disease), or with acute infectious diseases.
  • Have used or using glucocorticoids systemically within 3 months before admission.
  • Have participated in other medical clinical trials within 3 months before admission.
  • Patients with severe liver or kidney function abnormalities
  • Pregnant or lactating women.
  • Patients who lost follow-up.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Rate of popliteal artery stenosis < 50%, W.Wound treatmentIf the rate of popliteal artery stenosis of patients \< 50%, the patients only receive the wound treatment.
Rate of popliteal artery stenosis < 50%, WT.Tibial transverse transport surgeryIf the rate of popliteal artery stenosis of patients \< 50%, the patients receive the wound treatment and tibial transverse transport surgery.
Rate of popliteal artery stenosis ≥ 50%, WV.Wound treatmentIf the rate of popliteal artery stenosis of patients ≥ 50%, the patients receive the wound treatment and vascular intervention surgery.
Rate of popliteal artery stenosis ≥ 50%, WT.Wound treatmentIf the rate of popliteal artery stenosis of patients ≥ 50%, the patients receive the wound treatment and tibial transverse transport surgery.
Rate of popliteal artery stenosis ≥ 50%, WVT.Vascular intervention surgeryIf the rate of popliteal artery stenosis of patients ≥ 50%, the patients receive the wound treatment, vascular intervention and tibial transverse transport surgery.
Rate of popliteal artery stenosis < 50%, WT.Wound treatmentIf the rate of popliteal artery stenosis of patients \< 50%, the patients receive the wound treatment and tibial transverse transport surgery.
Rate of popliteal artery stenosis ≥ 50%, WV.Vascular intervention surgeryIf the rate of popliteal artery stenosis of patients ≥ 50%, the patients receive the wound treatment and vascular intervention surgery.
Rate of popliteal artery stenosis ≥ 50%, WVT.Wound treatmentIf the rate of popliteal artery stenosis of patients ≥ 50%, the patients receive the wound treatment, vascular intervention and tibial transverse transport surgery.
Rate of popliteal artery stenosis ≥ 50%, WT.Tibial transverse transport surgeryIf the rate of popliteal artery stenosis of patients ≥ 50%, the patients receive the wound treatment and tibial transverse transport surgery.
Rate of popliteal artery stenosis ≥ 50%, WVT.Tibial transverse transport surgeryIf the rate of popliteal artery stenosis of patients ≥ 50%, the patients receive the wound treatment, vascular intervention and tibial transverse transport surgery.
Primary Outcome Measures
NameTimeMethod
Healing rate of wound surface12 months after surgical operation
Secondary Outcome Measures
NameTimeMethod
Ankle-brachial index12 months after surgical operation
Recurrence rate of foot ulcer12 months after surgical operation

Trial Locations

Locations (1)

Peking University People's Hospital

🇨🇳

Beijing, China

© Copyright 2025. All Rights Reserved by MedPath